SanaCurrents Archives | GeoInvesting

May 19, 2023

SanaCurrents on Structure Thera’s (GPCR) new oral drug for Type II diabetes

This content is for members only

May 13, 2023

SanaCurrents on the FDA decision for Ocuphire’s (OCUP) Nyxol eye drops for consumers

This content is for members only

May 6, 2023

SanaCurrents on Immatics (IMTX) promising immunotherapy data to treat solid tumors

This content is for members only

April 29, 2023

SanaCurrents on Verrica’s (VRCA) drug-device combo to become the first treatment for benign skin disease in children

This content is for members only

April 22, 2023

SanaCurrents on Viridian’s (VRDN) rising challenger in thyroid eye disease (TED)

This content is for members only

April 15, 2023

SanaCurrents on ImmunoGen’s (IMGN) Elahere confirmatory trial in platinum-resistant ovarian cancer

This content is for members only

April 3, 2023

SanaCurrents on PTC Therapeutics’ (PTCT) entry into the rare disease Friedreich’s ataxia market

This content is for members only

March 25, 2023

SanaCurrents on FDA decision for IVERIC’s (ISEE) fast follower to treat a leading cause of blindness

This content is for members only